NYSE - Delayed Quote USD

Stevanato Group S.p.A. (STVN)

26.45 -0.36 (-1.34%)
At close: May 3 at 4:00 PM EDT
Loading Chart for STVN
DELL
  • Previous Close 26.81
  • Open 27.19
  • Bid 26.57 x 800
  • Ask 26.62 x 900
  • Day's Range 26.04 - 27.72
  • 52 Week Range 23.00 - 36.30
  • Volume 277,657
  • Avg. Volume 389,827
  • Market Cap (intraday) 7.215B
  • Beta (5Y Monthly) 0.70
  • PE Ratio (TTM) 44.83
  • EPS (TTM) 0.59
  • Earnings Date May 9, 2024
  • Forward Dividend & Yield 0.06 (0.23%)
  • Ex-Dividend Date Jun 7, 2023
  • 1y Target Est 34.76

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

www.stevanatogroup.com

5,635

Full Time Employees

December 31

Fiscal Year Ends

Recent News: STVN

Performance Overview: STVN

Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

STVN
3.08%
S&P 500
7.50%

1-Year Return

STVN
3.75%
S&P 500
24.47%

3-Year Return

STVN
--
S&P 500
18.50%

5-Year Return

STVN
--
S&P 500
18.50%

Compare To: STVN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: STVN

Valuation Measures

Annual
As of 5/3/2024
  • Market Cap

    7.21B

  • Enterprise Value

    7.56B

  • Trailing P/E

    44.87

  • Forward P/E

    39.37

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    6.03

  • Price/Book (mrq)

    5.94

  • Enterprise Value/Revenue

    6.97

  • Enterprise Value/EBITDA

    27.77

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    13.42%

  • Return on Assets (ttm)

    6.72%

  • Return on Equity (ttm)

    13.69%

  • Revenue (ttm)

    1.09B

  • Net Income Avi to Common (ttm)

    145.63M

  • Diluted EPS (ttm)

    0.59

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    72.18M

  • Total Debt/Equity (mrq)

    35.20%

  • Levered Free Cash Flow (ttm)

    -404.78M

Research Analysis: STVN

Company Insights: STVN

Research Reports: STVN

People Also Watch